Johnson & Johnson Form 8-K Summary
Business Context and Reporting Period
Johnson & Johnson (JNJ) filed a Current Report on Form 8-K on July 16, 2025. The filing announces the company's sales and earnings results for the second quarter ended June 29, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1) and the Unaudited Comparative Supplementary Sales Data (Exhibit 99.2), which are referenced but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It serves as a notification that the results for the period ended June 29, 2025, have been issued.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Such information is expected to be found in the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2025 revenue and earnings per share figures.
- Examine Exhibit 99.2 for detailed comparative sales data and the condensed consolidated statement of earnings.
- Verify any year-over-year growth rates and margin trends disclosed in the supplementary data.
- Check the press release for updated full-year 2025 guidance and management commentary on market conditions.